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Abstract
Background: Human milk is the subject of many studies, but procedures for representative sample collection have not
been established. Our improved methods for milk micronutrient analysis now enable systematic study of factors that
affect its concentrations.
Objective:We evaluated the effects of sample collection protocols, variations in circadian rhythms, subject variability, and
acute maternal micronutrient supplementation on milk vitamin concentrations.
Methods: In the BMQ (Breast-Milk-Quality) study, we recruited 18 healthy women (aged 18–26 y) in Dhaka, Bangladesh,
at 2–4mo of lactation for a 3-d supplementation study. On day 1, no supplements were given; on days 2 and 3, participants
consumed ;1 time and 2 times, respectively, the US-Canadian Recommended Dietary Allowances for vitamins at
breakfast (0800–0859). Milk was collected during every feeding from the same breast over 24 h. Milk expressed in the first
2 min (aliquot I) was collected separately from the remainder (aliquot II); a third aliquot (aliquot III) was saved by combining
aliquots I and II. Thiamin, riboflavin, niacin, and vitamins B-6, B-12, A, and E and fat were measured in each sample.
Results: Significant but small differences (14–18%) between aliquots were found for all vitamins except for vitamins B-6
and B-12. Circadian variance was significant except for fat-adjusted vitamins A and E, with a higher contribution to total
variance with supplementation. Between-subject variability accounted for most of the total variance. Afternoon and
evening samples best reflected daily vitamin concentrations for all study days. Acute supplementation effects were found
for thiamin, riboflavin, and vitamins B-6 and A at 2–4 h postdosing, with 0.1–6.17% passing into milk. Supplementation
was reflected in fasting, 24-h postdose samples for riboflavin and vitamin B-6. Maximum amounts of dose-responding
vitamins in 1 feeding ranged from 4.7% to 21.8% (day 2) and 8.2% to 35.0% (day 3) of Adequate Intake.
Conclusions: In the milk of Bangladeshi mothers, differences in vitamin concentrations between aliquots within feedings
and by circadian variance were significant but small. Afternoon and evening collection provided the most-representative
samples. Supplementation acutely affects some breast-milk micronutrient concentrations. This trial was registered at
clinicaltrials.gov as NCT02756026. J Nutr 2017;147:603–11.
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Introduction
The WHO recommends human milk as the sole food source for
infants aged 0–6 mo (1). Therefore, an exclusively breastfed infants
micronutrient status is dependent on the micronutrient concentra-
tion in breast milk, which can be greatly influenced by maternal
dietary intake and status, especially in the case of vitamins (2, 3).
However, very few data are available on nutrient concentrations in
human milk in wealthier regions, and even less is known in poor
populations. Although there is no reference range of concentrations
for micronutrients in human milk, its micronutrient concentration
4 Supplemental Tables 1 and 2 are available from the ‘‘Online Supporting
Material’’ link in the online posting of the article and from the same link in the
online table of contents at http://jn.nutrition.org.
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has been estimated from published reports to use as the basis for
making intake recommendations for breastfed infants and lactat-
ing women (4–7). However, the methods used for micronutrient
analyses in humanmilk were rarely described sufficiently and were
sometimes unsuitable for the complex human-milk matrix (8); in
some cases, the results obtained with different methods were not
comparable (3, 9, 10). We reported several validated methods for
accurately analyzing multiple vitamins in human milk (11–13),
which have now been used in various studies (14–21). Given the
undeniable importance of adequate micronutrient supply for an
infants growth and development, we still have only very limited
knowledge about the extent to which micronutrient concentra-
tions in breast milk are sufficient to meet an infants requirements.
Although correctly validated methods are necessary to
adequately measure the micronutrient concentration in breast
milk, the methods applied only reflect the concentration in the
sample as provided. Procedures for collecting milk samples vary
greatly among studies (e.g., opportunistic sample collection,
samples collected after a period of no-breastfeeding or at some
time during a feeding), samples may be with or without maternal
supplementation, and they often are not accompanied by
maternal dietary status data (15, 16, 19, 22–32). To what
extent these variations influence the micronutrient concentra-
tion of milk has not been assessed. Thus, a standardized and
optimized milk collection method is essential for a true assess-
ment of breast-milk micronutrients.
In this study, we collected milk from 18 Bangladeshi mothers
during every feeding from the same breast over 24 h, and
continued the sample collection protocol for another 48 h during
which the mothers received a single dose of a micronutrient
supplement with breakfast (0800–0900). Samples were analyzed
for retinol (vitamin A), tocopherol (vitamin E), thiamin (vitamin
B-1), riboflavin (vitamin B-2), nicotinamide (vitamin B-3),
vitamin B-6, and vitamin B-12 to examine 1) within-feeding
variation, 2) circadian variation and contributions due to subject
variability, 3) acute short-term effects of maternal supplemen-
tation on milk vitamin concentrations, and 4) the optimal time
for collection to determine which milk samples best represented
the daily median vitamin concentrations in milk.
Methods
Subjects and sample collection. For this 3-d observational supple-
mentation trial, 18 lactating mothers of infants aged 2–4 mo were
recruited at the International Centre for Diarrhoeal Disease Research,
Bangladesh (ICDDR,B)8, in Dhaka between October 2013 and February
2014. The recruitment methods and flow of participants are shown in
Figure 1. This research was approved by the Institutional Review Board
of the University of California, Davis, and ICDDR,B internal review
boards; and consent was obtained by the Bangladesh principal investi-
gator (clinicaltrials.gov; NCT02756026). The women provided in-
formed written consent in Bangla for themselves and their infants. The
number of participants was limited by the availability of resources. To be
eligible for the study, the women had to have a BMI (in kg/m2) >18.5 and
be at 2–4 mo of lactation and exclusively breastfeeding $12 times/d.
Furthermore, women and their infants had to have no pre-existing health
problems and if within the last week there had to be no signs of cold and
cough, difficulty breathing, fever, diarrhea, and, in the mother, no
mastitis.
The women and their infants arrived at the Clinical Trial Unit of the
ICDDR,B during the day before the first study day and stayed in the unit
for the duration of the study. Meals consisting of rice and dahl (a local
lentil dish) were low in micronutrients and provided throughout the
study. There were no differences between the meals for each day. The
first breast-milk sample was collected from the overnight-fasted mother
in the morning of the first study day between 0800 and 0859 by the study
nurses. During every feeding, milk was collected by using the Medela
Symphony electronic hospital-grade breast pump (Medela) from the
same breast for 24 h, allowing the infant to suckle from the other breast.
Milk expressed during the first 2 min (aliquot I) was collected separately
by a specially designed funnel attached to the nipple shield into a 50 mL
conical tube (Corning, Inc.); the remainder (aliquot II) of the breast
content was collected into the pumps milk bottle provided by the
manufacturer until the breast was emptied. A third aliquot (aliquot III)
was saved by transferring the remaining milk from collection (I) into the
bottle containing aliquot II. From each aliquot (I, II, and III), 2 3 1 mL
(sample and backup) were gently mixed before transferring into 2-mL
amber screw-cap tubes (Fisher Scientific) by using plastic disposable
transfer pipettes (Fisher Scientific) and immediately stored at 220C on
site. After aliquots were taken, the remaining milk was available for
spoon-feeding by the mother. The same milk-collection protocol was
followed on days 2 and 3, but women received supplements con-
taining ;1 time and ;2 times, respectively, the US-Canadian RDA in a
capsule (Nutri-Fem; Thorne Research; Supplemental Table 1) provided
during breakfast by the study personnel. On day 4, a final fasting breast-
milk sample was obtained before the participants were discharged from
the Clinical Trial Unit. Milk volume was not recorded. The milk samples
(aliquots I, II, and III) were shipped on dry ice to the USDA–Agricultural
Research Service Western Human Nutrition Research Center in Davis,
California, for analysis, and the backup samples remained on site at the
ICDDR,B.
Biochemical analyses. Unless otherwise stated, all milk aliquots (I, II,
and III) were analyzed by using the following methods. Riboflavin, FAD,
nicotinamide, and pyridoxal were analyzed as previously described (13),
with a few modifications. Samples were analyzed after protein precip-
itation and removal of nonpolar constituents with methyl-tert-butyl ester
(Fisher Scientific) with the use of a Waters Alliance 2695 HPLC coupled
FIGURE 1 Flowchart of study participants in the Breast-Milk-Quality
Study. Eighteen apparently healthy Bangladeshi women were enrolled
in the study. 1Three aliquots of breast milk were collected from the
same breast during every feeding for the duration of the study (I: the
first 2 min into the feeding; II: the remainder of the feeding; III: full-
breast aliquot obtained by combining I and II). BM, breast milk.
8 Abbreviations used: ABC, ATP-binding cassette; BCRP, breast cancer–-
resistant protein; ICDDR,B, International Centre for Diarrhoeal Disease
Research, Bangladesh; SLC, solute carrier; THTR1, thiamin transporter 1;
THTR2, thiamin transporter 2; vitamin Afat, vitamin A adjusted for milk fat; vitamin
Efat, vitamin E adjusted for milk fat.
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to a Micromass Micro Quattro mass spectrometer (Waters). Analytes
were separated by using a Waters Atlantis T3 (3 mm, 2.1 mm 3 75 mm)
column guarded by a Thermo Scientific BDS-hypersil C18 Javelin guard
(3 mm, 3 mm 3 20 mm) (Thermo Fisher Scientific) maintained at 40C.
Free thiamin, thiamin monophosphate, and thiamin pyrophosphate
were analyzed via HPLC–fluorescence detector using an Agilent 1200
Series HPLC system (Agilent) after precolumn derivatization to their
thiochrome esters (11). Retinol, b-carotene, and a-tocopherol were
analyzed as described (33), with some modifications: only 100-mL
samples were used for analysis with an Agilent Eclipse Plus C18 column
(3.5 mm, 2.1 mm 3 100 mm) guarded by a Thermo Scientific BDS-
hypersil C18 Javelin guard (3 mm, 3 mm3 20 mm) maintained at 30C.
Twenty-five microliters were injected at a flow rate of 0.6 mL/min and a
total run time of 4.5 min. Vitamin B-12 in breast milk was analyzed as
previously described by using the Siemens Immulite automated, quan-
titative immuno-analyzer (12).
Creamatocrit and fat contents were determined by using Creama-
tocrit Plus (Medela) according to the manufacturers protocol. A control
strip provided by the manufacturer was used to verify the tube readers
accuracy.
Statistical analyses. The outcomes were concentrations of thiamin
(vitamin B-1; free thiamin + thiamin monophosphate + thiamin pyrophos-
phate), riboflavin (vitamin B-2; riboflavin + FAD), niacin (vitamin B-3;
nicotinamide), vitamin B-6 (pyridoxal), vitamin B-12, vitamin A (retinol +
b-carotene), and vitamin E (a-tocopherol), and fat-adjusted vitamins A
(vitamin Afat; retinol + b-carotene per gram of milk fat) and E (vitamin Efat;
a-tocopherol, the active form of vitamin E, per gram of milk fat) in breast
milk. SAS for Windows, release 9.4 (SAS Institute), was used for all
statistical analyses. Logarithmic transformations were performed on
riboflavin, niacin, vitamin B-6, vitamin A, vitamin Afat, vitamin Efat, fat,
and the square root transformation vitamin E to normalize the skewed
data. No transformation was needed for thiamin and vitamin B-12. All of
the aliquots (I, II, and III) obtained on day 1 were used to examine the
differences in concentrations between these aliquots (within-feeding
variation), because no supplements were consumed, with the use of
general linear models (GLM procedure; SAS), with time, aliquot, and
subject included as fixed categorical effects. This approach showed that
aliquot III is the preferred aliquot to be collected; thus, all subsequent
statistical analyses were carried out with the use of aliquot III only.
The GLMprocedure was also used to explore the differences between
the fasted samples of each day (days 1–4; acute supplementation effects
on fasted samples), with day and subject used as fixed categorical effects.
Mixed-model analysis (MIXED procedure; SAS) was used to explore
the differences in concentrations by day (days 1–3; acute short-term
effects of supplementation) to identify the timing of the sample whose
concentration was closest to the daily overall concentrations (optimal
time for collection) and to estimate the percentage of variance due to
hourly fluctuation and due to within- and between-subject variability. All
mixed models included subject as a categorical random effect. Analyses
involving multiple comparisons were adjusted with Tukey-Kramer test.
To compare vitamin concentrations of a given time interval with the
overall daily concentrations, the samples (aliquot III) from all subjects
combined for a given day were categorized on the basis of time of
collection (1-h time intervals during 0800–2000 and 2-h time intervals
during 2000–0800). P values <0.05 were considered to be significant.
Median concentrations for each time interval were used for solely
illustrative purposes in the tables and figures.
Efficacy of maternal supplementation. The efficacy of maternal
supplementation was estimated for vitamins in breast milk that showed
significant acute short-term supplementation effects (P < 0.05). Therefore,
the increases in vitamin concentrations due to supplementation were
estimated by using the differences in daily median concentrations for days
1–3 (day 2 compared with day 1, day 3 compared with day 1, day 3
compared with day 2). After adjusting to the average milk intake for
infants of 0.78 L/d, this median daily increase in concentration was
compared with 1) the respective amount provided by the supplement
and 2) the respective values used to set the Adequate Intake. To examine
the maximum dose provided to the infant in a single feeding, the highest
median concentrations of a responding vitamin at any given time interval
within a day were used to estimate the maximum amount provided
within a feeding. Calculations were based on an average feeding frequency
in this study of 10 feedings/d and 780 mL milk consumed by the infant/d.
Results
Maternal characteristics at initial visit. The women recruited
for the study were housewives between 18–26 y of age with a
BMI in the normal range (Table 1). Of the participants, 83.3%
had some level of education and 94.4% lived in a household
with an income above the minimum wage. Only 1 participant
reported current vitamin use, whereas 83.3% of the women
reported the use of various supplements during pregnancy.
TABLE 1 Characteristics of Bangladeshi mothers 2–4 mo
postpartum participating in the BMQ study1
Characteristics Values
Maternal characteristics
Age, y 20 (18, 22)
Weight, kg 47 (42, 53)
Height, cm 149 (145, 152)
BMI, kg/m2 22 (19, 24)
Any education, % 83.3
Income . minimum wage, % 94.4
Current vitamin use, % 5.6
Supplements in pregnancy, n (%)
Iron + calcium + VD 7 (38.9)
Iron 3 (16.7)
Iron + BV 1 (5.6)
Iron + MNs 1 (5.6)
Iron + calcium 1 (5.6)
Ca + VD 1 (5.6)
MNs 1 (5.6)
No supplement use, n (%) 3 (16.7)
1 Values are medians (IQRs) unless otherwise indicated; n = 18. BMQ, Breast-Milk-
Quality; BV, B-vitamin complex; MN, micronutrient; VD, vitamin D.
FIGURE 2 Differences betweenmilk aliquots collected within a feeding
during a day without maternal supplementation. Values are medians (95%
CIs); n = 187 from 18 apparently healthy Bangladeshi mothers at 2–4 mo
of lactation. Labeled medians without a common letter differ, P, 0.05. I1,
first 2 min of the feeding; II, remainder of the feeding; III, full-breast aliquot
obtained by combining I and II. General linear models were used to explore
the differences in concentration between aliquots on day 1. All concen-
trations are mg/L except for B12 (ng/L), Afat and Efat (nmol/L), Fat (g/L),
A (mg/100 mL), and E (mg/10 mL). A, vitamin A; Afat, vitamin A adjusted for
milk fat; B1, thiamin; B2, riboflavin; B3, niacin (nicotinamide); B6, vitamin
B-6; B12, vitamin B-12; E, vitamin E; Efat, vitamin E adjusted for milk fat;
Fat, milk fat.
Effects of breast-milk collection on vitamin concentration 605
TABLE 2 Circadian variations in breast-milk concentrations for thiamin, riboflavin, niacin, fat, and vitamins B-6, B-12, A, and E
for days 1–31
Time (24 h)2 n
Vitamin or fat, %
Thiamin Riboflavin Niacin Vitamin B-6 Vitamin B-12 Vitamin A Vitamin E Fat Vitamin Afat Vitamin Efat
Day 1
0800–0859 17 85* 70* 82 94 121 80 97 90 101 103
0900–0959 3 95 39 42 126 34 119 98 117 101 91
1000–1059 12 91 133 102 103 74* 138 119 105 94 105
1100–1159 10 101 83 122 106 146* 98 101 96 81 116
1200–1259 6 118* 169* 75 116 61 84 107 87 108 116
1300–1359 11 100 96 79 94 117 107 112 114 108 83
1400–1459 9 103 95 166 131 137* 117* 142* 123* 96 101
1500–1559 8 115 101 73 106 119 120 105 133 82 89
1600–1659 12 85 121 112 88 94 119 101 93 132 108
1700–1759 9 108 102 99 107 75 71 87 108 82 93
1800–1859 9 81 86 117 92* 162 146 136 112 107 111
1900–1959 7 107 153 125 136* 146 90 105 96 185 109
2000–2159 20 103 111 88 105 126 121 96 111 127 82
2200–2359 12 124 131 93 113 105 126 82 89 122 90
0000–0159 12 98 79 112 69* 75 69* 83* 78* 80 93
0200–0359 11 96* 79* 50* 67* 59* 69 82 80 81 90
0400–0559 10 108* 146 102 67 63* 109* 81 80 128 95
0600–0759 9 76* 61* 80* 71* 108 87 84 90 92 108
Daily median3 187 137 34.3 265 86.9 145 48.8 45.1 58.4 29.4 182
Variance due to circadian fluctuation, % 3.7 2.1 3.0 3.0 8.6 5.4 5.5 8.7 ,0.5 ,0.5
Variance due to between-subject variability, % 81.8 86.3 73.7 76.8 54.6 56.7 48.0 18.7 67.2 58.4
Variance due to within-subject variability, % 14.5 11.6 23.3 20.2 36.8 37.9 46.5 72.6 32.8 41.6
Day 2
0800–0859 17 90* 69* 69 76 92 126 118* 96 120 109
0900–0959 7 100 159* 116 105* 55 98 123 111 88 90
1000–1059 8 86 127* 85 86 145 132 130 120* 118 104
1100–1159 10 107* 167* 97 127* 54 119 113 100 112 118
1200–1259 12 97* 136* 103* 119* 131 99* 125* 111 87 114
1300–1359 4 117 220 155 128 172* 210 93 106 203 68
1400–1459 8 110 106 100 78 132 120* 113* 131* 91 81
1500–1559 10 112 113 115 128 85 146 103 104 129 98
1600–1659 10 88 80 90* 108 156 113* 147* 100 92 110
1700–1759 10 110 95 115 93 118 119 99 104 134 78
1800–1859 4 105 119 154 82 89 107 117 129 82 80
1900–1959 8 76 68 67 91 123 101 116 79 155 112
2000–2159 16 111 97 101 85 72 92 94 96 92 86
2200–2359 17 93 100 109 103 100 101 79 103 102 119
0000–0159 10 94* 78 80 59* 84 76* 77* 64* 110 127
0200–0359 10 82* 62* 66* 111 89 69* 87* 76* 84 113
0400–0559 5 113 125 108* 113 72 111 70 74 155 84
0600–0759 13 74* 76* 75* 114 74 78* 91 83 91* 85
Daily median3 179 160 45.1 229 126 146 53.2 42.3 55.7 32.3 190
Variance due to circadian fluctuation, % 3.4 6.6 3.1 5.5 3.2 6.8 6.9 15.4 ,0.5 ,0.5
Variance due to between-subject variability, % 85.3 79.6 79.1 74.5 49.9 66.1 51.8 8.4 67.7 46.9
Variance due to within-subject variability, % 11.3 13.8 17.8 19.9 46.9 27.2 41.2 76.2 32.3 53.1
Day 3
0800–0859 16 86* 61* 96 69* 88 91 107 106 85 88
0900–0959 7 99 167* 97 83 61 107 135 119 100 113
1000–1059 8 101 972* 105 228* 102 96 107 129 108 86
1100–1159 10 107 476* 88 134* 82 76 90 89 93 111
1200–1259 8 99* 188* 168* 210* 125* 139* 131* 101 142* 102
1300–1359 11 132* 288* 78* 283* 84 114 118 106 115* 93
1400–1459 6 95 114 117 183* 86 142* 100* 77 153* 137*
1500–1559 14 118* 133 140* 107 118* 125* 111 117* 101 107
1600–1659 6 83 70 81* 111 124 114 120 104 72 108
(Continued)
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Differences between aliquots I, II, and III within a day. The
differences in vitamin concentrations between the collected
aliquots I, II, and III were examined on day 1, when no
supplementation was provided. No significant differences were
found for vitamins B-6 and B-12 (Figure 2). When compared
with the full-breast aliquot III, aliquot I was significantly lower
in concentrations of niacin, fat, vitamin Afat, and vitamin Efat,
whereas aliquot II was significantly higher for thiamin and
vitamins A, E, Afat, and Efat. None of these differences were large
(>20% between aliquots). Thus, any further analyses included
only the concentrations obtained from aliquot III.
Circadian variation and subject variability. Regardless of the
day, the circadian variation in concentration was significant for
all vitamins (P < 0.001), except for vitamins A and E when
adjusted for milk fat. However, the contribution of the circadian
variation to the total variance was <10% for all vitamins, but
increased considerably with maternal supplementation for
riboflavin (36%) and vitamin B-6 (23%) (Table 2, Supplemental
Table 2).
On day 1 (no supplements), vitamin Efat showed the lowest
range of variation throughout a day (82–116%), whereas the
greatest range was observed for riboflavin (39–169%). The
optimal collection times were 0900–0959, 1300–1359, 1500–
1759, and during the evening, 2000–2359 (Table 2).
On day 2, the first day of supplementation (1 capsule),
thiamin varied least from the daily median (74–117%), whereas
riboflavin showed the greatest range (62–220%). Increases in
concentrations of >200% of the daily median were observed for
riboflavin within 4 h after the supplement was taken. The
optimal collection times were between 1500–1559 and 1700–
2359 showing no significant differences between the measured
vitamin concentrations during these time intervals and the
overall daily median concentrations.
The second day of using a higher dose of supplement (day 3)
showed the same pattern for the vitamins with the smallest range
(thiamin: 80–132%) and the greatest range (riboflavin: 41–972%).
Riboflavin and vitamin and B-6 increased by >200% of their daily
median concentrations within 2–4 h after supplementation.
Differences in concentrations for all vitamins from their daily
concentrations were not significant between 1800 and 1959.
Although circadian variation represented only a minor con-
tribution to the total variance, the between-subject variability
accounted for a majority of the total variance for most of the
vitamins on all days (46.9–86.3%; Table 2), with the exception
of riboflavin on day 3 (30.1%) when the variance of the
TABLE 2 Continued
Time (24 h)2 n
Vitamin or fat, %
Thiamin Riboflavin Niacin Vitamin B-6 Vitamin B-12 Vitamin A Vitamin E Fat Vitamin Afat Vitamin Efat
1700–1759 7 116 151 103 102* 131 190 89 101 188 97
1800–1859 9 107 94 162 126 132 88 101 112 93 97
1900–1959 6 121 121 123 117 101 123 71 93 97 76
2000–2159 16 94 71* 87 82 83 88 108 98 100 98
2200–2359 17 89 62* 126 80* 113 88 97 97 89 105
0000–0159 4 97* 57* 66 54* 61 78 86 85 80 95
0200–0359 9 98* 86 108* 77* 61* 75 80 97 104 83
0400–0559 10 83* 42* 85* 64* 98 64 87 88 100 116
0600–0759 9 80* 41* 92* 94* 126* 71* 83 70* 72 126*
Daily median3 173 166 64.7 193 214 145 60.2 41.9 56.0 37.9 172
Variance due to circadian fluctuation, % 8.8 40.5 6.2 23.9 3.9 5.8 2.0 7.0 ,0.5 0.9
Variance due to between-subject variability, % 70.0 30.5 82.4 59.3 66.9 59.5 48.1 23.9 64.3 59.9
Variance due to within-subject variability, % 21.2 29.0 11.4 16.8 29.2 34.8 49.9 69.1 35.4 39.2
1 Values are relative medians (%) compared with the daily median unless otherwise indicated. Relative median: for each day, medians were determined for each time interval as
shown and divided by the overall daily median. Values were obtained from mean values of aliquot III (full-breast aliquot) of the milk sample collection from 18 healthy Bangladeshi
mothers at 2–4 mo of lactation. Mixed-model analysis of transformed values was used to identify the most-representative sample collection time and to estimate the percentage
of variance due to hourly fluctuation and subject variability. *Different from the daily median, P , 0.05. Fat, milk fat; Vitamin Afat, vitamin A adjusted for milk fat; vitamin Efat,
vitamin E adjusted for milk fat.
2 The optimal times for collection with no significant differences of concentrations from the daily median are as follows: Day 1: 0900–0959, 1300–1359, 1500–1759, 2000–2359;
Day 2: 1500–1559, 1700–2359; Day 3: 1800–1959.
3 Vitamin A (mg/100 mL); vitamin Afat (nmol/g milk fat); thiamin, riboflavin, niacin, and vitamin B-6 (mg/L); vitamin B-12 (ng/L); vitamin E (mg/10 mL); vitamin Efat (nmol/g milk fat); fat (g/L).
FIGURE 3 Relative daily concentrations of vitamins and fat in breast
milk during maternal supplement consumption on days 2 (1 capsule)
and 3 (2 capsules). Values are medians (95% CIs); day 1, n = 187;
day 2, n = 179; day 3, n = 173 from 18 women. Labeled medians
without a common letter differ, P , 0.05. Relative median concen-
trations (%) are based on median concentrations on day 1 (set to
100% by default) and median concentrations on days 2 and 3. Only
the full-breast aliquots (aliquot III) were considered. The mixed-model
analysis was used to examine for differences in concentrations by
day. A, vitamin A; Afat, vitamin A adjusted for milk fat; B1, thiamin; B2,
riboflavin; B3, niacin (nicotinamide); B6, vitamin B-6; B12, vitamin
B-12; E, vitamin E; Efat, vitamin E adjusted for milk fat; Fat, milk fat.
Effects of breast-milk collection on vitamin concentration 607
circadian variation increased to 36%, most likely due to
maternal supplementation. The between-subject variability was
consistently lower for fat than for the vitamins on all days (8.9–
23.8%), whereas the within-subject variability was lower for
vitamins (11.3–53.1%; Table 2) than for the fat content (69.1–
76.2%).
Acute effects of supplementation. Thiamin, riboflavin, and
vitamins B-6, A, and Afat concentrations in breast milk were
significantly increased when supplements were consumed (Fig-
ure 3), with median increases >180% (riboflavin and vitamin
B-6) and 120–130% (thiamin and vitamins A and Afat)
compared with the median baseline value of day 1. Niacin and
vitamin E both showed significantly lower concentrations on
days when supplements were consumed. No effects of acute
supplementation were found for vitamin B-12 and Efat
concentrations.
Even though the increase in all 4 vitamins was significant
and substantial from both doses, only 0.05–0.35% of thiamin,
0.54–0.6% of riboflavin, 1.0–1.14% of vitamin B-6, and
4.85–6.17% of vitamin A in the supplements were secreted
into the breast milk and subsequently available to the infant
(Table 3). All of the vitamins except for thiamin showed a
positive linear dose-response relation; thiamin secretion into
the milk was 4 times more efficient on day 1 compared with
day 2. However, when compared with their Adequate Intakes,
only 2.3–11.1% of thiamin, 2.8–7.9% of riboflavin, and
8.6–22.3% of vitamin A were transferred to the milk via
maternal supplement, whereas 30.7–98.9% of the Adequate
Intake was provided by maternal vitamin B-6 supplementa-
tion. The maximum dose provided in 1 single feeding ranged
between 1.5% and 13.9% of the Adequate Intake when no
supplements were provided, which increased to 8.2–35%
when supplements were given.
TABLE 3 Estimate of the acute effects of supplementation on thiamin, riboflavin, and vitamins B-6
and A in fasting milk samples collected from healthy Bangladeshi women who consumed 1 (day 2) and 2
(day 3) capsules of the micronutrient supplement1
Thiamin Riboflavin Vitamin B-6 Vitamin A
Day, μg/L
1 137 (108, 179)2 34.3 (17, 56) 86.9 (54, 117) 532 (353, 829)
2 160 (113, 185) 45.1 (26, 80) 126 (80, 191) 566 (409, 897)
3 166 (131, 199) 64.7 (33, 113) 214 (146, 281) 651 (466, 930)
Increase, μg/L
On day 2 22.6 10.8 39.3 34.0
On day 3 vs. day 2 6.0 19.6 87.5 84.7
On day 3 vs. day 1 28.6 30.4 127 119
Increase based on infant intake (0.78 L/d), μg/d
On day 2 17.7 8.4 30.7 26.5
On day 3 vs. day 2 4.6 15.3 68.3 66.1
On day 3 vs. day 1 22.3 23.7 98.9 92.6
Supplemental amount received, mg
Day 2 5 1.4 3 0.56
Day 3 vs. day 2 10 2.8 6 1.1
Day 3 vs. day 1 15 4.2 9 1.7
Supplement secreted into breast milk,3 %
Day 2 0.35 0.60 1.0 4.7
Day 3 vs. day 2 0.05 0.54 1.1 6.0
Day 3 vs. day 1 0.14 0.56 1.1 5.5
Supplement amount received,4 % of Adequate Intake
Adequate Intake for infants aged 0–6 mo, μg/d 200 300 100 400
Day 2, % of Adequate Intake 8.8 2.8 30.7 6.6
Day 3 vs. day 2, % 2.3 5.1 68.3 16.6
Day 3 vs. day 1, % 11.1 7.9 98.9 23.2
Median maximum concentration,5 μg/L
Day 1 169 58.1 118 711
Day 2 187 99.1 162 1117
Day 3 211 438 449 1142
Amounts provided at maximum,6 μg/feeding (% of Adequate Intake)
Day 1 13.2 (6.6) 4.5 (1.5) 9.2 (9.2) 55.4 (13.9)
Day 2 14.6 (7.3) 7.7 (4.7) 12.6 (12.6) 87.1 (21.8)
Day 3 16.4 (8.2) 34.2 (11.4) 35.0 (35.0) 89.1 (22.3)
1 n = 18. Samples were obtained from milk aliquot III collected from healthy Bangladeshi mothers at 2–4 mo of lactation.
2 Median; IQR in parentheses (all such values).
3 Increase based on infant intake compared with the supplemental amount received.
4 Increase based on infant intake compared with Adequate Intake values (4, 6).
5 Highest median concentration measured at any given time interval within a day.
6 Estimated amount of vitamin in a single feeding at maximum median concentrations based on an average of 10 feedings/d and 780 mL
daily consumption = 78 mL, presented as micrograms per feeding (% of Adequate Intake).
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Supplementation effects in fasting milk samples. Nutrient
concentrations in the fasting milk samples collected on each
study day (days 1–4) were compared to evaluate possible
supplementation effects on fasting milk samples, which also
represented samples collected at the maximum time after the
supplements were consumed. No significant differences were
observed for thiamin and vitamins B-12, Afat, Efat, and A (Table 4).
Vitamin B-6 concentrations increased linearly after supple-
ments were consumed, whereas milk concentrations of ribo-
flavin increased on day 3 and 4 compared with day 1.
Concentrations on day 2 did not differ from day 1 or days 3
and 4. Lower concentrations were found for niacin and vitamin
E, but only on day 4.
Discussion
Although numerous studies that required breast-milk collection
have been conducted over decades, little systematic attention
was given to the influence of the collection conditions on
breast-milk nutrient concentrations. Moreover, the differences
in sample collection methods exacerbated uncertainties in the
comparison of the results between different studies.
The objective of the BMQ (Breast-Milk-Quality) study was
to determine which milk aliquot collected best represented the
daily median milk vitamin concentration and how single-dose
maternal supplement consumption affects milk vitamin concen-
trations. Thus, the study was not designed to detect differences
in milk composition on the basis of stage of lactation, to estimate
infant intakes, or to evaluate long-term supplementation effects.
Because the breast milk was collected on the basis of the infants
desire to breastfeed, the time points of milk collection were
irregular and produced a different number of samples for the
different time intervals and therefore resulted in variable power
to detect differences. Because the milk volume was not recorded,
the actual infant intake of the micronutrients could not be
estimated.
We found significant differences between the 3 aliquots (I, II,
and III) collected within a feeding for some of the vitamins
analyzed (thiamin, riboflavin, niacin, vitamin A, vitamin Afat,
vitamin Efat, and fat), whereas others (vitamins B-6 and B-12)
were not affected. Although Greibe et al. (29) found higher
amounts of vitamin B-12 in hindmilk than in foremilk, Trugo and
Sardinha (34) found no differences in vitamin B-12 concentration
within feedings, between breasts, or over the day. The latter report
is in agreement with our findings. Hence, depending on the
nutrient of interest and the aliquot collected, concentrations
obtained for some vitamins may under- or overestimate the actual
concentrations in milk by#20%, indicating that an aliquot from
the full-breast volume is the preferred milk sample. Circadian
variation was significantly influenced by time of sample collection
within a day, but the contribution to the total variance was
relatively small. In contrast, the variation due to between-subject
variability represented the main contributor to the total variance.
Other factors, such as recent or current intake and/or vitamin
status and genetics, are likely to influence the total variances in
vitamin concentrations among women, which need to be quan-
tified in future studies.
When supplements were consumed, the contribution of
circadian variance to the total variance increased, implicating an
acute effect of maternal supplementation at least for some of the
vitamins analyzed. However, with or without supplements, the
best representative time for sample collection was during the late
afternoon and evening hours. Without supplementation, the
morning hours (0900–0959) and early afternoon hours (1500–
1559) were also acceptable for sample collection based on their
lower variation in vitamin concentrations, whereas increases
in the concentration of riboflavin and vitamin B-6 in milk
during the early afternoon on days 2 and 3 reflected acute effects
of maternal supplementation. Nevertheless, the course of the
day appeared to be sufficient to negate these acute supplemen-
tation effects when the supplement was consumed in the early
morning (0800–0859) and allowed the collection of samples
that represented the daily median vitamin concentration during
the evening. Due to the observed time between supplement
consumption and concentration increases in the vitamins, any
supplement consumption occurring later in the day is expected
to shift the timing of a representative sample collection toward
later hours in the evening. Whether or not evening consumption
of supplements allows for representative milk samples in the
morning has yet to be determined. Given the metabolic
differences between the active and the resting hours, vitamin
secretion might also be subjected to the slower metabolism. The
acute response of riboflavin and vitamin B-6 also enabled the
estimate of 1) a maximum dose of these vitamins in the milk
during maternal supplementation and, subsequently, 2) a max-
imum amount provided to the infant. Such information could
aid in kinetic studies that include the rate and amount of vitamin
uptake into breast milk and subsequent availability to the infant.
TABLE 4 Concentrations of all nutrients analyzed in fasting milk samples collected from healthy
Bangladeshi women who consumed 1 (day 2) and 2 (day 3) capsules of the micronutrient supplement1
Nutrient Day 1 (n = 17) Day 2 (n = 17) Day 3 (n = 16) Day 4 (n = 18) P
Thiamin, μg/L 116 (102, 156) 144 (109, 176) 143 (106, 195) 152 (117, 174) 0.07
Riboflavin, μg/L 24b (15, 41) 31a,b (14, 55) 40a (21, 70) 35a (21, 49) 0.06
Niacin, μg/L 219a,b (161, 295) 158b (138, 434) 185a,b (114, 338) 159a (87, 286) 0.03
Vitamin B-6, μg/L 81c (67, 103) 96b,c (65, 154) 148a,b (109, 246) 211a (164, 283) ,0.001
Vitamin B-12, ng/L 175 (85, 224) 134 (75, 199) 128 (78, 198) 103 (78, 180) 0.26
Vitamin Afat, μmol/g fat 30 (18, 54) 39 (26, 56) 33 (22, 52) 39 (25, 56) 0.09
Vitamin Efat, μmol/g fat 188 (119, 237) 207 (183, 256) 151 (126, 213) 196 (153, 284) 0.36
Fat, g/L 52a,b (37, 70) 54a (48, 68) 60a (49, 67) 39b (30, 52) 0.03
Vitamin A, μg/L 391 (314, 561) 669 (371, 907) 547 (447, 762) 391 (314, 561) 0.11
Vitamin E, μg/L 4.4a,b (3.5, 6.1) 5.0a (3.9, 7.4) 4.5a,b (3.3, 5.8) 3.2b (2.1, 3.8) 0.06
1 Values are medians (IQRs); n = 18. Samples were obtained from milk aliquot III collected from healthy Bangladeshi mothers at 2–4 mo
of lactation. Samples were collected between 0800 and 0859 before breakfast, ;24 h after the last supplement consumption, and before
the dose of the day. P values were obtained by using a generalized linear model. Labeled medians in a row without a common superscript
letter differ, P , 0.05. Fat, milk fat; vitamin Afat, vitamin A adjusted for fat; vitamin Efat, vitamin E adjusted for fat.
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Little information is available with regard to the mechanisms of
vitamin secretion into breast milk (35). Water-soluble vitamins are
thought to be actively secreted involving members of the solute
carrier (SLC) and ATP-binding cassette (ABC) family; breast cancer–
resistant protein (BCRP) is associated with riboflavin secretion,
vitamin B-12 uptake might be partly dependent on a receptor-
mediated system, and thiamin transporters THTR1 and THTR2
may be involved in thiamin secretion. The transport mechanisms
involved with niacin and vitamin B-6 are unknown (11, 35). The
regulation of fat-soluble vitamins A and E appears to occur
through a specific transport system independent from lipid transfer,
but the mechanisms involved have not been revealed (36, 37).
Given that only 0.05–6.17% of the detectable acute median
responses to the supplemented vitamins were reflected in the milk,
the uptake of the single-dose supplement into milk was very
limited. Nevertheless, in the case of vitamin B-6, this limited
secretion accounted for ;30–100% of the value assumed to set
the Adequate Intake for infants aged 0–6mo.Moreover, we found
that the acute effects of maternal supplementation remained
significant for riboflavin and vitamin B-6 in the fasting milk
samples 24 h after supplementation compared with day 1, and
that the vitamins were not secreted into milk at the same rate
throughout a day during maternal supplementation, resulting in a
bolus dose of #35% of the Adequate Intake for vitamin
B-6 during a single feeding, whereas the bolus dose for riboflavin
during a single feeding only provided ;11% of the Adequate
Intake. These results showed that the relative increases in milk
vitamin concentrations were substantial and likely to improve
infant status. In addition, the reported fact that maternal
supplementation caused a subsequent change in infant status of
some vitamins, which reflects the amount supplied to the mother,
supported the effective enrichment of these vitamins in milk.
In conclusion, diurnal variation in and timing of sample collection
within a feeding are both significant but are only minor contributors
to the total variance. However, the time of the recent supplement
administration is crucial for deciding on the timing of breast-milk
collection when establishing representative values for milk micro-
nutrient concentrations and the effectiveness of micronutrient pro-
grams. Further evaluation of vitamin secretion into milk is needed to
examine the relation between the dose and frequency of maternal
supplementation and to fully understand the potential efficacy of
supplements for improving the delivery of vitamins to the infant.
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